These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36222759)

  • 1. CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy.
    Berger PA; Freitag J; Linkenbach SC; Merz L; Schork M; Thevissen S; Yildiz I; Beck JD
    Hum Vaccin Immunother; 2022 Nov; 18(6):2124785. PubMed ID: 36222759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
    Billmeier A; Khinvasara K; Lang F; Mohr J; Reidenbach D; Schork M; Yildiz I; Diken M
    Hum Vaccin Immunother; 2022 Dec; 18(1):2024416. PubMed ID: 35130105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIMT 2018: Pushing frontiers in cancer immunotherapy - Report on the 16
    Beck J; Birtel M; Reidenbach D; Salomon N; Diken M
    Hum Vaccin Immunother; 2018; 14(12):2864-2873. PubMed ID: 30111232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy.
    Ahrberg Y; Dallmann J; Freitag J; Hassan A; Jung C; Kiefer J; Muralidharan AM; Peter M; Beck JD
    Hum Vaccin Immunother; 2024 Dec; 20(1):2381925. PubMed ID: 39043196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy.
    Dallmann J; Freitag J; Jung C; Khinvasara K; Merz L; Peters D; Schork M; Beck JD
    Immunooncol Technol; 2023 Dec; 20():100397. PubMed ID: 37876518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy.
    Beck JD; Birtel M; Haefner E; Keil IS; Reidenbach D; Salomon N; Yildiz IG; Diken M
    Hum Vaccin Immunother; 2020 Apr; 16(4):808-815. PubMed ID: 31584850
    [No Abstract]   [Full Text] [Related]  

  • 7. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
    Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471
    [No Abstract]   [Full Text] [Related]  

  • 8. CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany.
    Kranz LM; Birtel M; Hilscher L; Grunwitz C; Petschenka J; Vascotto F; Vormehr M; Voss RH; Kreiter S; Diken M
    Hum Vaccin Immunother; 2016 Nov; 12(11):2805-2812. PubMed ID: 27435168
    [No Abstract]   [Full Text] [Related]  

  • 9. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 10. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
    Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
    Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy.
    Kranz LM; Birtel M; Krienke C; Grunwitz C; Petschenka J; Reuter KC; van de Roemer N; Vascotto F; Vormehr M; Kreiter S; Diken M
    Hum Vaccin Immunother; 2016; 12(1):213-21. PubMed ID: 26186022
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
    Theelen J; Braun J; Hörzer H; Kloke BP; Ott M; Pizzitola I; Schirmer U; Miller M
    Cancer Immunol Immunother; 2017 May; 66(5):673-681. PubMed ID: 28251274
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.
    Gulley JL; Repasky EA; Wood LS; Butterfield LH
    J Immunother Cancer; 2017 Jul; 5(1):55. PubMed ID: 28716068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
    Balwit JM; Kalinski P; Sondak VK; Coulie PG; Jaffee EM; Gajewski TF; Marincola FM
    J Transl Med; 2011 May; 9():60. PubMed ID: 21569425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015.
    Miller M; Jahndel V; Kutscher S; Mahr A; Rae R; Kloke BP
    Cancer Immunol Immunother; 2016 Oct; 65(10):1277-87. PubMed ID: 27259506
    [No Abstract]   [Full Text] [Related]  

  • 16. Translating Science into Survival: Report on the Fourth International Cancer Immunotherapy Conference.
    Diken M; Ravoori S; Brodsky AN
    Cancer Immunol Res; 2019 Jan; 7(1):2-5. PubMed ID: 30602506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating Science into Survival: Report on the Inaugural International Cancer Immunotherapy Conference.
    Hubbard-Lucey VM; Tontonoz MJ
    Cancer Immunol Res; 2016 Jan; 4(1):3-11. PubMed ID: 27119139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.
    Miyahira AK; Kissick HT; Bishop JL; Takeda DY; Barbieri CE; Simons JW; Pienta KJ; Soule HR
    Prostate; 2015 Mar; 75(4):337-47. PubMed ID: 25358693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating Science into Survival: Report on the Second International Cancer Immunotherapy Conference.
    Brodsky AN; Hubbard-Lucey VM
    Cancer Immunol Res; 2016 Dec; 4(12):996-1000. PubMed ID: 27908930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31
    Adusumilli PS; Cha E; Cornfeld M; Davis T; Diab A; Dubensky TW; Evans E; Grogan JL; Irving BA; Leidner RS; Olwill SA; Soon-Shiong P; Triebel F; Tuck D; Bot A; Dansey RD; Drake CG; Freeman GJ; Ibrahim R; Patel S; Chen DS
    J Immunother Cancer; 2017; 5():50. PubMed ID: 28649381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.